…
Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical services, specialty medical, chronic condition management, and mental health services, as well as technologies and enterprise telehealth solutions for hospitals and health systems. Its BetterHelp segment operates a mental health platform that provides online counselling and therapy services through websites, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc and BetterHelp brands. It serves employers, health plans, hospitals and health systems, insurance companies, and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in New York, New York.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -235.53M | -993.65M | -219.61M | -13663.34M | -384.66M |
| Net income | -200.32M | -1001.25M | -220.37M | -13659.53M | -428.79M |
| Selling general administrative | 431.89M | 435.49M | 464.66M | 449.86M | 438.01M |
| Selling and marketing expenses | 653.37M | 910.78M | 902.63M | 850.71M | 667.31M |
| Gross profit | 1758.38M | 1818.30M | 1842.38M | 1662.85M | 1382.45M |
| Reconciled depreciation | 376.43M | 382.84M | 351.32M | 270.64M | 219.62M |
| Ebit | -215.82M | -208.79M | -210.50M | -13739.77M | -238.99M |
| Ebitda | 147.30M | 31.72M | 43.61M | -13469.12M | -14.28M |
| Depreciation and amortization | 363.12M | 240.51M | 254.11M | 270.64M | 224.71M |
| Non operating income net other | - | - | - | -0.86M | -38.66M |
| Operating income | -262.95M | -1020.89M | -248.55M | -13198.48M | -238.99M |
| Other operating expenses | 2792.93M | 3590.46M | 2850.97M | 2634.21M | 2271.70M |
| Interest expense | 19.71M | 23.80M | 22.28M | 9.27M | 80.36M |
| Tax provision | -35.21M | 7.59M | 0.76M | -3.81M | 44.14M |
| Interest income | 36.77M | 57.07M | 46.78M | - | - |
| Net interest income | 17.06M | 33.27M | 24.50M | -9.27M | -80.36M |
| Non recurring | - | - | - | 13425.85M | 26.64M |
| Income tax expense | -35.21M | 7.59M | 0.76M | -3.81M | 44.14M |
| Total revenue | 2529.98M | 2569.57M | 2602.41M | 2406.84M | 2032.71M |
| Total operating expenses | 2021.34M | 2839.19M | 2090.94M | 1890.22M | 1621.44M |
| Cost of revenue | 771.59M | 751.27M | 760.03M | 743.99M | 650.26M |
| Total other income expense net | 27.43M | 27.23M | 28.95M | -26861.83M | -145.67M |
| Net income from continuing ops | -200.32M | -1001.25M | -220.37M | -13659.53M | -428.79M |
| Net income applicable to common shares | - | - | - | -13659.53M | -428.79M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 3100.80M | 3516.52M | 4392.37M | 4345.35M | 17734.61M |
| Intangible assets | 1297.09M | 1431.36M | 1677.78M | 1836.77M | 1910.28M |
| Other current assets | 66.36M | 103.49M | 105.80M | 130.31M | 87.39M |
| Total liab | 1715.09M | 2025.44M | 2066.30M | 2037.61M | 1688.85M |
| Total stockholder equity | 1385.71M | 1491.08M | 2326.07M | 2307.74M | 16045.76M |
| Deferred long term liab | - | - | - | 54.81M | 2.40M |
| Other current liab | 283.43M | 239.94M | 257.01M | 248.03M | 195.50M |
| Common stock | 0.18M | 0.17M | 0.17M | 0.16M | 0.16M |
| Capital stock | 0.18M | 0.17M | 0.17M | 0.16M | 0.16M |
| Retained earnings | -16430.22M | -16229.90M | -15228.66M | -15008.29M | -1421.45M |
| Other liab | - | - | - | 56.43M | 81.10M |
| Good will | 283.19M | 283.19M | 1073.19M | 1073.19M | 14504.17M |
| Other assets | - | - | - | 48.54M | 20.70M |
| Cash | 781.08M | 1298.33M | 1123.67M | 918.18M | 893.48M |
| Total current liabilities | 404.74M | 941.53M | 420.62M | 399.77M | 331.01M |
| Current deferred revenue | 62.30M | 79.30M | 95.66M | 90.46M | 75.57M |
| Net debt | 259.08M | 286.29M | 468.60M | 655.15M | 373.96M |
| Short term debt | 11.04M | 561.06M | 10.75M | 13.59M | 12.69M |
| Short long term debt | - | 550.72M | - | - | - |
| Short long term debt total | 1040.17M | 1584.61M | 1592.28M | 1573.33M | 1267.44M |
| Other stockholder equity | 17850.48M | 17759.19M | 17591.55M | 17358.65M | 17473.34M |
| Property plant equipment | - | - | - | 29.64M | 74.01M |
| Total current assets | 1087.31M | 1663.91M | 1489.05M | 1315.39M | 1225.44M |
| Net tangible assets | - | - | - | -556.09M | -368.69M |
| Short term investments | - | - | - | 0.00M | 2.54M |
| Net receivables | 201.66M | 223.96M | 230.06M | 210.55M | 168.96M |
| Long term debt | 994.92M | 991.42M | 1538.69M | 1535.29M | 1225.67M |
| Inventory | 38.20M | 38.14M | 29.51M | 56.34M | 73.08M |
| Accounts payable | 47.97M | 33.13M | 43.64M | 47.69M | 47.26M |
| Accumulated other comprehensive income | -34.73M | -38.39M | -36.99M | -42.78M | -6.29M |
| Common stock total equity | - | - | - | 0.16M | 0.16M |
| Retained earnings total equity | - | - | - | -15008.29M | -1421.45M |
| Non currrent assets other | 137.62M | 81.49M | 80.26M | 48.54M | 20.70M |
| Non current assets total | 2013.49M | 1852.62M | 2903.32M | 3029.97M | 16509.17M |
| Capital lease obligations | 45.24M | 42.47M | 53.59M | 38.04M | 41.77M |
| Long term debt total | - | - | - | 1535.29M | 1225.67M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -27.14M | -124.05M | -173.73M | 2.51M | 60.90M |
| Change to liabilities | - | - | - | 5.03M | 21.74M |
| Total cashflows from investing activities | -266.00M | -124.05M | -156.35M | -167.74M | -72.98M |
| Net borrowings | -550.63M | 0.00M | 0.00M | -3.15M | -0.91M |
| Total cash from financing activities | -551.65M | 8.31M | 10.85M | 6.50M | 40.95M |
| Change to operating activities | - | - | - | -31.25M | -35.06M |
| Net income | -200.32M | -1001.25M | -220.37M | -13659.53M | -428.79M |
| Change in cash | -517.24M | 174.65M | 205.49M | 24.70M | 160.16M |
| Begin period cash flow | 1298.33M | 1123.67M | 918.18M | 893.48M | 733.32M |
| End period cash flow | 781.08M | 1298.33M | 1123.67M | 918.18M | 893.48M |
| Total cash from operating activities | 294.36M | 293.68M | 350.02M | 189.29M | 193.99M |
| Depreciation | 363.12M | 382.84M | 348.72M | 270.64M | 219.62M |
| Other cashflows from investing activities | -175.95M | -113.26M | 0.00M | -153.77M | 8.71M |
| Change to inventory | 0.40M | -9.75M | 24.09M | 14.80M | -19.49M |
| Change to account receivables | 25.13M | -0.38M | -10.25M | -61.64M | -17.51M |
| Sale purchase of stock | - | - | -0.28M | 12.38M | 42.59M |
| Other cashflows from financing activities | -4.11M | -0.00M | -0.28M | 0.61M | 41.09M |
| Change to netincome | - | - | - | 13635.81M | 453.49M |
| Capital expenditures | 8.89M | 10.79M | 156.35M | 172.76M | 63.93M |
| Change receivables | - | - | - | -61.64M | -17.51M |
| Cash flows other operating | - | - | - | -1.20M | 84.29M |
| Cash and cash equivalents changes | - | - | - | 28.05M | 161.96M |
| Change in working capital | 1.07M | -36.31M | 11.64M | -60.97M | -50.32M |
| Stock based compensation | 80.41M | 145.95M | 201.55M | 217.85M | 302.59M |
| Other non cash items | 91.48M | 803.59M | 10.38M | 13429.14M | 109.10M |
| Free cash flow | 285.46M | 282.89M | 193.67M | 16.53M | 130.06M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| TDOC Teladoc Inc |
-0.22 2.52% |
8.51 | - | 303.03 | 0.48 | 0.91 | 0.59 | 6.77 |
| VEEV Veeva Systems Inc Class A |
2.62 0.84% |
312.96 | 43.49 | 29.59 | 12.48 | 5.79 | 10.39 | 33.41 |
| PMCUF Pro Medicus Limited |
- -% |
137.03 | 64.90 | 90.91 | 49.11 | 38.05 | 65.12 | 83.47 |
| TEM Tempus AI, Inc. Class A Common Stock |
-5.62 7.22% |
72.22 | - | - | 8.68 | 25.39 | 8.33 | - |
| MTHRY M3 Inc |
-0.03 0.52% |
5.77 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical services, specialty medical, chronic condition management, and mental health services, as well as technologies and enterprise telehealth solutions for hospitals and health systems. Its BetterHelp segment operates a mental health platform that provides online counselling and therapy services through websites, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc and BetterHelp brands. It serves employers, health plans, hospitals and health systems, insurance companies, and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in New York, New York.
155 E 44th Street, New York, NY, United States, 10017
203 635 2002
4648
| Name | Title | Year Born |
|---|---|---|
| Mr. Jason Nathanial Gorevic | CEO & Director | 1972 |
| Ms. Mala Murthy | Chief Financial Officer | 1964 |
| Mr. Adam Christian Vandervoort | Chief Legal Officer & Sec. | 1975 |
| Mr. Andrew Turitz | Sr. VP of Corp. Devel. | 1973 |
| Mr. Claus Torp Jensen Ph.D. | Chief Innovation Officer | NA |
| Dr. George Byron Brooks | Co-Founder | NA |
| Mr. Mike Waters | Chief Operating Officer | NA |
| Mr. Richard J. Napolitano | Sr. VP, Chief Accounting Officer & Controller | 1967 |
| Mr. Patrick Thomas Feeley C.F.A., CPA | VP of Investor Relations | NA |
| Ms. Courtney Kraemer McLeod | Director of Communication | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.